Cbl-C forms are often associated with AKI secondary to thrombotic microangiopathy, thus potentially requiring RRT for AKI; this has been reported in both infants and adults [18,19,20], and a case of eculizumab treatment has also been reported [21]. This evidence concerns the gene CBLC and thrombotic microangiopathy.